Company Name, Ticker, Competitors, else..

Evofem Biosciences Inc (EVFM)

Other Ticker:

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry ../Industry/industry_growth_rates.php?oper&ind=803"> • Major Pharmaceutical Preparations

Sector • Healthcare

Evofem Biosciences Inc

EVFM's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

EVFM Growth rates comparisons

Looking into Evofem Biosciences Inc growth rates, revenue grew by 272.14 % in III. Quarter 2022 from the same quarter a year ago. Ranking at No. 723

Major Pharmaceutical Preparations industry recorded growth of revenues by 0.82 %

Evofem Biosciences Inc realized net income compared to net loss a year ago in III. Quarter 2022

• More on EVFM's Growth

EVFM's Valuation comparisons

Evofem Biosciences Inc
realized net loss in trailing twelve months.

Evofem Biosciences Inc realized cash outflow of $ -0.03per share in trailing twelve-month period.

Company

-0

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 0.38.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.45.

• More on EVFM's Valuation

Total Debt (Millions $)	52
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	2.62
Tangible Book Value (Per Share $)	-0.14

EVFM's Valuation comparisons

Evofem Biosciences Inc
realized net loss in trailing twelve months.

Evofem Biosciences Inc realized cash outflow of $ -0.03per share in trailing twelve-month period.

Company

-0

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 0.38.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.45.

• More on EVFM's Valuation

• Market Capitalization (Millions $)	8
• Shares Outstanding (Millions)	555
• Employees	-
• Revenues (TTM) (Millions $)	20
• Net Income (TTM) (Millions $)	-119
• Cash Flow (TTM) (Millions $)	-15
• Capital Exp. (TTM) (Millions $)	0
• Total Debt (Millions $)	52
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	2.62
• Tangible Book Value (Per Share $)	-0.14

• Market Capitalization (Millions $)	8
• Shares Outstanding (Millions)	555
• Employees	-
• Revenues (TTM) (Millions $)	20
• Net Income (TTM) (Millions $)	-119
• Cash Flow (TTM) (Millions $)	-15
• Capital Exp. (TTM) (Millions $)	0

	*Ratio*
• Capital Ratio (MRQ)	0.27
• Total Debt to Equity (MRQ)	-
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	0.47
• Inventory Turnover Ratio (TTM)	-

EVFM's Profitability Comparisons

Evofem Biosciences Inc net profit margin of 1404.9 % is currently ranking no. 5 in Major Pharmaceutical Preparations industry, ranking no. 8 in Healthcare sector and number 32 in S&P 500.

• More on EVFM's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar VRNA's Profile Stock Price VRNA's Financials Business Description Fundamentals Charts & Quotes VRNA's News Suppliers VRNA's Competitors Customers & Markets Economic Indicators VRNA's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071